Viewing Study NCT06497582



Ignite Creation Date: 2024-07-17 @ 11:25 AM
Last Modification Date: 2024-10-26 @ 3:34 PM
Study NCT ID: NCT06497582
Status: RECRUITING
Last Update Posted: 2024-07-12
First Post: 2024-05-28

Brief Title: Self-acupressure and Zhan Zhuang for Symptom Cluster Management
Sponsor: The Hong Kong Polytechnic University
Organization: The Hong Kong Polytechnic University

Study Overview

Official Title: Self-acupressure and Zhan Zhuang for Pain Fatigue and Sleep Disturbance in Breast Cancer Survivors A Pilot Randomized Controlled Trial
Status: RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The proposed study will be a 3-arm parallel-group randomized controlled trial on the effects of self-acupressure and Zhan-Zhuang for alleviating pain fatigue and sleep disturbance in breast cancer survivors Subjects will include 54 breast cancer survivors who have experienced a moderate level of pain fatigue and sleep disturbance All eligible subjects will be randomized into one of the three groups in a 111 ratio Zhan Zhuang group or self-acupressure group or wait list control group Subjects in the Zhan-Zhuang group will receive up to 8 weeks of the intervention consisting of a training course over two weeks followed by self-practice for 6 weeks Those in the self-acupressure group will attend an acupressure training course for two weeks and then will be asked to practice self-acupressure for 6 weeks The wait list control group will be provided with delayed self-acupressure or Zhan Zhuang at the end of the study Outcome assessment will be conducted at baseline week 8 post-intervention and week 12 4 week follow-up Primary outcomes include pain fatigue and sleep disturbance Secondary outcomes include psychological distress and health-related quality of life Qualitative data will be collected from selected participants who have received the intervention
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None